Galapagos NV (GXEA) - Total Liabilities

Latest as of March 2026: €119.06 Million EUR ≈ $139.19 Million USD

Based on the latest financial reports, Galapagos NV (GXEA) has total liabilities worth €119.06 Million EUR (≈ $139.19 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Galapagos NV to track the company's year-over-year net asset growth rate.

Galapagos NV - Total Liabilities Trend (2016–2025)

This chart illustrates how Galapagos NV's total liabilities have evolved over time, based on quarterly financial data. See Galapagos NV (GXEA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Galapagos NV Competitors by Total Liabilities

The table below lists competitors of Galapagos NV ranked by their total liabilities.

Company	Country	Total Liabilities
Welspun Living Limited NSE:WELSPUNLIV	India	Rs54.45 Billion
Skywater Technology Inc NASDAQ:SKYT	USA	$545.05 Million
Kirloskar Brothers Limited NSE:KIRLOSBROS	India	Rs15.61 Billion
Akzo Nobel India Limited NSE:AKZOINDIA	India	Rs13.44 Billion
Alkami Technology Inc NASDAQ:ALKT	USA	$458.69 Million
Kelington Group Bhd KLSE:0151	Malaysia	RM645.95 Million
Nanhua Futures Co Ltd SHG:603093	China	CN¥59.67 Billion
Guangdong Baolihua New Energy Stock Co LTD SHE:000690	China	CN¥8.83 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Galapagos NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GXEA market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	30.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Galapagos NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Galapagos NV (2016–2025)

The table below shows the annual total liabilities of Galapagos NV from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€170.65 Million ≈ $199.51 Million	-86.22%
2024-12-31	€1.24 Billion ≈ $1.45 Billion	-20.68%
2023-12-31	€1.56 Billion ≈ $1.83 Billion	-29.28%
2022-12-31	€2.21 Billion ≈ $2.58 Billion	-13.39%
2021-12-31	€2.55 Billion ≈ $2.98 Billion	-16.33%
2020-12-31	€3.05 Billion ≈ $3.56 Billion	-4.56%
2019-12-31	€3.19 Billion ≈ $3.73 Billion	+1317.53%
2018-12-31	€225.25 Million ≈ $263.34 Million	-17.88%
2017-12-31	€274.29 Million ≈ $320.68 Million	-15.51%
2016-12-31	€324.64 Million ≈ $379.53 Million	--

About Galapagos NV

F:GXEA Germany Biotechnology

Market Cap

$1.82 Billion

€1.56 Billion EUR

Market Cap Rank

#6889 Global

#995 in Germany

Share Price

€23.60

Change (1 day)

-1.67%

52-Week Range

€23.00 - €31.40

All Time High

€246.00